Apton Biosystems
Re-imagining optical systems for sequencing and protein detection using super-resolution to evaluate molecules spaced closer than a wavelength of light.
Launch date
Employees
Market cap
-
Enterprise valuation
€91—136m (Dealroom.co estimates Jun 2021.)
Pleasanton California (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Late VC | ||
$25.0m | Series A | ||
* | $85.0m | Acquisition | |
| Total Funding | €22.7m | ||
Related Content
Recent News about Apton Biosystems
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.